Search Results - Alverlind, Sofie

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Population pharmacokinetics of TC-5214, a nicotinic channel modulator, in phase I and II clinical studies

    Population pharmacokinetics of TC-5214, a nicotinic channel modulator, in phase I and II clinical studies by Xu, Hongmei, Henningsson, Anja, Alverlind, Sofie, Tummala, Raj, Toler, Steven, Beaver, Jessica S., Al-Huniti, Nidal

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Clinical Pharmacokinetics of the Nicotinic Channel Modulator Dexmecamylamine (TC-5214) in Subjects with Various Degrees of Renal Impairment

    Clinical Pharmacokinetics of the Nicotinic Channel Modulator Dexmecamylamine (TC-5214) in Subjects with Various Degrees of Renal Impairment by Alverlind, Sofie, Barassin, Stéphane, Dalén, Per, Li, Yan, Toler, Steven, Eriksson, Hans, Tummala, Raj

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteers

    Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteers by Boström, Emma, Bohnstedt, Kristina Claeson, Jostell, Karl-Gustav, Alverlind, Sofie, Huledal, Gunilla, Paulsson, Björn, Hårdemark, Hans-Göran, Öhd, John, Lindholm, Sara

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: